Medically reviewed by Jessica Swirble, PharmDLast updated on April 17, 2025
Drug Information| | |
Celebrex is a medication classified as a Non-steroidal Anti-Inflammatory Drug (NSAID). This selective COX-2 inhibitor blocks the activity of a body’s own cyclooxygenase (COX-1) enzyme, thereby inhibiting the production of prostaglandins, which are pro-inflammatory mediators. This selectivity makes Celebrex an effective option for pain relief.
Key Features:
Benefits:
Celecoxib is the brand name for Celebrex, a COX-2 inhibitor. Approved by the FDA in 2002, Celecoxib is a newer COX-2 inhibitor with a shorter mechanism of action. It works by inhibiting the production of prostaglandins, which are pro-inflammatory mediators, and helps to alleviate pain, cough, and inflammation associated with tissue injury, particularly in the lungs, airways, or abdomen.
The COX-2 inhibitor Celebrex is prescribed for the treatment of pain in muscle, lower abdominal wall, or lower back tissue, as well as for the prevention of cancer, dental procedures, and other complications associated with COX-2 inhibitors like cancer chemotherapy or NSAIDs. It also helps reduce the risk of heart attack, stroke, and bone fractures when compared to traditional NSAIDs like NSAIDs alone.
The COX-2 inhibitor Celecoxib is available in capsules or suspension form in a liquid form and is typically given as an oral tablet. The dosage and frequency of administration depend on the condition being treated, the severity of pain, and any other medications being taken.
Celebrex is usually taken orally once daily at approximately four-hourly intervals over a 24-hour period, usually one hour before food. It is important to take the medication as directed by your healthcare provider to ensure proper absorption and effectiveness.
Follow your healthcare provider's instructions for the dosage and frequency of Celebrex administration based on your prescription needs.
| |uv0RvCfJ|3e20|32.814|0.86|0.8|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0>|Side Effects
|
The most common side effects with Celebrex are fatigue, mild to moderate abdominal pain, nausea, diarrhea, and headache. Patients with a history of ulcers and gastrointestinal bleeding should use the non-steroidal anti-inflammatory drug (NSAID) Celebrex for pain relief.
Common Side Effects
• Headache (feeling or being sick)
• Nasal congestion
• Runny nose
• Upset stomach
• Muscle pain
The most common side effects with Celebrex are mild to moderate abdominal pain, mild to moderate pain in lower back, lower abdominal wall, and diarrhea.
AstraZeneca today announced the celecoxib celecoxib, a Cox-2 inhibitor, was approved by the U. S. Food and Drug Administration (FDA) on September 26, 2019.
Celecoxib, an orally administered, selective nonsteroidal anti-inflammatory drug (NSAID) was the first oral selective COX-2 inhibitor to receive FDA approval for the treatment of osteoarthritis (OA) in the absence of other NSAIDs. Celecoxib (Celebrex) was launched on the same day, October 28, 2019, and was approved for the treatment of rheumatoid arthritis (RA) on February 27, 2020.
The FDA’s approval of Celebrex for the treatment of RA was based on its clinical experience with Celebrex and the results of an open-label, randomized, controlled trial conducted over two years.
“Today’s announcement marks a significant milestone in the ongoing efforts of AstraZeneca to bring innovative pharmaceuticals to market to enable patients and healthcare providers to better manage their chronic pain and manage their disease,” said John W. Campbell, MD, President and CEO of AstraZeneca.
“Celecoxib was first approved for the treatment of osteoarthritis, a debilitating condition affecting millions of people worldwide. We are excited to work with AstraZeneca to bring innovative pharmaceuticals to market to enable patients and healthcare providers to better manage their chronic pain and manage their disease,” said Dr. Campbell.
Celebrex is a selective COX-2 inhibitor that targets the COX-1 and COX-2 enzymes in the body. By blocking the COX-2 enzyme, Celebrex reduces prostaglandins, which cause inflammation and pain.
“We are delighted to announce the approval of Celebrex for the treatment of RA, a disease that has become a global health concern,” said AstraZeneca’s Mark E. Taylor, MD, Director of Global Health. “We are excited to work with AstraZeneca to bring innovative pharmaceuticals to market to enable patients and healthcare providers to better manage their chronic pain and manage their disease.”
Celebrex will be available in generic form on the AstraZeneca website for the following dosage forms:
Form:Oral Celecoxib Celebrex capsules, capsules, delayed-release (or oral) Celebrex tablets, oral capsule-containing formulations, and delayed-release (or oral) Celebrex oral capsule capsules
Dosage Form:Oral Celecoxib Celebrex capsule, Celebrex tablets, oral capsule-containing formulations, oral capsule-containing formulations, delayed-release (or oral) Celebrex oral capsule capsules
Administration:COX-2 selective inhibitors are commonly used in the management of pain due to osteoarthritis (OA) and rheumatoid arthritis (RA). They work by blocking the production of certain natural substances that cause pain and inflammation.
COX-2 selective inhibitors are available orally as capsules and oral capsules. Oral Celebrex capsules, Celebrex tablets, and oral capsules are available by prescription.
Interactions:As with any medication, Celebrex may have some interactions with other medications, medical conditions, or supplements.
Dosage Forms:Oral Celebrex Celecoxib Celebrex tablets, Celebrex capsules, and delayed-release (or oral) Celebrex oral capsule capsules
Adverse Event/Common Use:There have been concerns that Celebrex may cause the stomach to become inflamed and cause pain, which could lead to gastrointestinal bleeding. In addition, Celebrex has been associated with an increased risk of heart attack, stroke, and heart failure, which increases the risk of heart attacks and strokes.
Contraindications:Patients with a history of cardiovascular disease, uncontrolled hypertension, or a history of heart disease, stroke, liver disease, or uncontrolled high blood pressure, are at greater risk of developing certain serious adverse effects.
Mechanism of Action:Celecoxib selectively inhibits COX-2 enzyme production, reducing prostaglandin synthesis. Consequently, Celebrex (celecoxib) selectively inhibits COX-1 and COX-2. Consequently, Celebrex (celecoxib) selectively inhibits the prostaglandin synthesis.
We are very happy to report that Celebrex (celecoxib) has been approved by the FDA for treatment of osteoarthritis. Celebrex is indicated for the relief of acute pain, stiffness, and pain in people with rheumatoid arthritis (RA) who have not responded to traditional non-steroidal anti-inflammatory drugs (NSAIDs) for at least six months or for a period of six months, as required. We also received a letter from the US Food and Drug Administration (FDA) advising us that celecoxib should not be used in people with an active peptic ulcer.
Celebrex (celecoxib) was approved by the US FDA in April 2003 for the treatment of RA in adults. Celebrex is indicated for the relief of mild to moderate pain and is not indicated for use in the acute pain of rheumatoid arthritis (RA) in adults.
Celebrex is indicated for the treatment of acute pain in people with RA in adults.
We are very happy to report that a letter from the US Food and Drug Administration (FDA) advising us that celecoxib has been approved by the US FDA for treatment of RA in adults.
We are very happy to report that an application for the US FDA’s (US FDA’s Adjuvant Pain Care Program) for Celebrex (celecoxib) has been submitted to the FDA by the USFDA for approval.
We are very happy to report that a letter from the USFDA for the USFDA’s (US FDA’s Adjuvant Pain Care Program) for Celebrex (celecoxib) has been submitted to the FDA for approval by the USFDA for treatment of RA in adults.
Copyright © 2025 KSM HealthWe are very happy to report that our treatment plan has been approved by the USFDA for treatment of RA in adults.
The USFDA also has the following approved and accepted treatment plans for RA in adults:
We have reviewed all of the information contained in the USFDA-approved treatment plans with the following comments and recommendations. If you have any questions please speak to your physician or pharmacist.
We are very happy to report that the Celebrex (celecoxib) has been approved by the USFDA for treatment of RA in adults. The USFDA has recommended that this drug be used only to be used in patients with RA. The USFDA has also indicated that this drug should not be used in people with an active peptic ulcer. The USFDA has advised that this drug should not be used in patients with a history of peptic ulcers.
The USFDA has also advised that this drug should not be used in patients with a history of peptic ulcers.
Celebrex, a brand-name prescription drug, is an effective painkiller that belongs to the class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). It is often prescribed for conditions such as osteoarthritis, rheumatoid arthritis, and juvenile arthritis. However, there are several drawbacks to using this medication:
While Celebrex offers many benefits for treating arthritis, it also has some drawbacks. One of the drawbacks of using Celebrex is its potential side effects. When taking Celebrex, some people may experience gastrointestinal issues like diarrhea, constipation, or abdominal pain. These side effects are usually mild and tend to disappear as your body adjusts to the drug.
Another drawback to using Celebrex for long-term pain management is the risk of severe allergic reactions. While Celebrex can cause a mild allergic reaction, it can also cause serious side effects if you are allergic to the drug. In addition, Celebrex is not suitable for everyone and its usage may be contraindicated for pregnant women or women who are lactose intolerant.
Another drawback of using Celebrex for long-term pain management is the risk of severe side effects. Celebrex is known to cause gastrointestinal issues like ulcers and bleeding. If you have these symptoms, your doctor may want to prescribe Celebrex for long-term pain management.
Several factors can affect the way Celebrex works. One of the most significant factors is the dosage. The dosage of Celebrex for long-term pain management can vary depending on the specific condition being treated. For example, if you have a higher dosage than 200 mg per day, it may be a good idea to take a lower dose of Celebrex. It's also important to be aware that certain dosages may cause gastrointestinal side effects like diarrhea, which can be a serious problem.
Another factor to consider is the patient population. Celebrex is available only by prescription and has to be prescribed by a doctor. Patients who have been prescribed Celebrex for long-term pain management are typically prescribed a lower dosage, as it may not be suitable for everyone. For those who have severe side effects, Celebrex can be used for more than two months. It is important to monitor your progress closely to ensure that Celebrex remains effective and safe.
Celebrex is known for its unique advantages compared to other NSAIDs. Unlike many other NSAIDs, Celebrex is not a "typical" painkiller. It has fewer gastrointestinal side effects, such as indigestion or diarrhea, and it has fewer serious side effects compared to other NSAIDs. Celebrex has also proven effective in reducing inflammation and reducing pain.
Moreover, Celebrex has been shown to reduce the risk of heart attacks and strokes in people with certain heart conditions. This makes Celebrex a valuable addition to the arsenal against heart conditions.
The use of Celebrex for long-term pain management can have various disadvantages. The risks of side effects are generally low compared to other NSAIDs. However, Celebrex is not a "typical" painkiller, but rather a more targeted medication that can be used for chronic pain management. It can also lead to the development of drug interactions and complications, making it more challenging for a patient to achieve long-term pain relief.
Celebrex is not suitable for everyone. Patients who have a history of allergic reactions to NSAIDs or other NSAIDs should not use Celebrex for long-term pain management. It should be used with caution in those with a history of heart attack or stroke. Patients who take Celebrex for long-term pain management should also avoid taking the medication for this purpose.
Although Celebrex is generally safe for most people, there are some disadvantages associated with its use. One of the advantages is the potential for side effects. Celebrex can cause mild stomach discomfort and gastrointestinal upset, but it can also cause more serious side effects like allergic reactions.
Stade de France Pharmacy